Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02775292 |
|---|---|
| Brief Title: | Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 (NYM) |
| First Submitted : | May 13, 2016 |
| First Submitted that Met QC Criteria : | May 13, 2016 |
| First Posted : | May 17, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 22, 2020 |
| Last Update Posted : | July 24, 2020 |